BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan

[1]  P. Aloy,et al.  Functional and Structural Analysis of C-Terminal BRCA1 Missense Variants , 2013, PloS one.

[2]  R. Mariani-Costantini.  Diagnosis: Breast cancer screening in rural African communities , 2013, Nature Reviews Clinical Oncology.

[3]  Lawal AbdulRazzaq Oluwagbemiga,et al.  Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review , 2012, SpringerPlus.

[4]  O. Olopade,et al.  High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients , 2012, International journal of cancer.

[5]  E. Rosenthal,et al.  Clinical significance of large rearrangements in BRCA1 and BRCA2 , 2012, Cancer.

[6]  R. Mariani-Costantini,et al.  Cancer in the Sudan: an overview of the current status of knowledge on tumor patterns and risk factors. , 2012, The Science of the total environment.

[7]  R. Mariani-Costantini,et al.  Hereditary Breast Cancer in Sub-Saharan Africa , 2012 .

[8]  Fergus J Couch,et al.  A review of a multifactorial probability‐based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) , 2012, Human mutation.

[9]  R. Greenberg.  BRCA1, Everything But the RING? , 2011, Science.

[10]  Dominique Vaur,et al.  Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes , 2011, European Journal of Human Genetics.

[11]  J. Glover,et al.  Impact of BRCA1 BRCT Domain Missense Substitutions on Phosphopeptide Recognition , 2011, Biochemistry.

[12]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[13]  Majid Masso,et al.  AUTO-MUTE: web-based tools for predicting stability changes in proteins due to single amino acid replacements. , 2010, Protein engineering, design & selection : PEDS.

[14]  O. Olopade,et al.  Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population , 2010, Breast Cancer Research and Treatment.

[15]  J. Glover,et al.  Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. , 2010, Cancer research.

[16]  Sue Healey,et al.  Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity , 2010, Human mutation.

[17]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[18]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[19]  Alun Thomas,et al.  Classification of rare missense substitutions, using risk surfaces, with genetic‐ and molecular‐epidemiology applications , 2008, Human mutation.

[20]  A. Spurdle,et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.

[21]  Y. Nominé,et al.  Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations. , 2008, Biochemistry.

[22]  S. Tishkoff,et al.  African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. , 2008, Annual review of genomics and human genetics.

[23]  Sue Healey,et al.  Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Blasio,et al.  Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa , 2008, Histopathology.

[25]  Andrej Sali,et al.  Functional Impact of Missense Variants in BRCA1 Predicted by Supervised Learning , 2006, PLoS Comput. Biol..

[26]  R. Mariani-Costantini,et al.  BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors , 2007, Breast Cancer Research and Treatment.

[27]  Andrew J. Bulpitt,et al.  Predicting the effect of missense mutations on protein function: analysis with Bayesian networks , 2006, BMC Bioinformatics.

[28]  M. Michael Gromiha,et al.  CUPSAT: prediction of protein stability upon point mutations , 2006, Nucleic Acids Res..

[29]  Xiaowei Chen,et al.  Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression , 2006, Human mutation.

[30]  Shunsuke Kato,et al.  Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods , 2006, Nucleic acids research.

[31]  A. Zharkikh,et al.  Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral , 2005, Journal of Medical Genetics.

[32]  T. Scholl,et al.  Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. , 2005, Mutation research.

[33]  Drew M. Lowery,et al.  Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer , 2004, Nature Structural &Molecular Biology.

[34]  Francisco E. Baralle,et al.  Genomic variants in exons and introns: identifying the splicing spoilers , 2004, Nature Reviews Genetics.

[35]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[36]  J. Glover,et al.  Structural Consequences of a Cancer-causing BRCA1-BRCT Missense Mutation* , 2003, The Journal of Biological Chemistry.

[37]  O. Olopade,et al.  Breast cancer genetics in African Americans , 2003, Cancer.

[38]  I. Biunno,et al.  High-quality genomic DNA from human whole blood and mononuclear cells. , 2002, BioTechniques.

[39]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[40]  L. Serrano,et al.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. , 2002, Journal of molecular biology.

[41]  T. Dork,et al.  BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. , 2002, Saudi medical journal.

[42]  S. Henikoff,et al.  Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.

[43]  J. Glover,et al.  Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1 , 2001, Nature Structural Biology.

[44]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[45]  P. Møller,et al.  Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. , 2001, Human molecular genetics.

[46]  E. Gross,et al.  Identification of specific BRCA1 and BRCA2 variants by DHPLC. , 2000, Human mutation.

[47]  A. Sali,et al.  Modeling of loops in protein structures , 2000, Protein science : a publication of the Protein Society.

[48]  B. Ward,et al.  BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site. , 1999, American journal of medical genetics.

[49]  A. Bowcock,et al.  The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression* , 1998, The Journal of Biological Chemistry.

[50]  H. Hanafusa,et al.  Evidence for a transcriptional activation function of BRCA1 C-terminal region. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  I. Verma,et al.  Transcriptional activation by BRCA1 , 1996, Nature.

[52]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.